During today's trading session, Mankind Pharma experienced a notable price increase of 2.24%, with the stock price reaching Rs 2432.00. This movement occurred amidst a backdrop of very bearish investor sentiment, as indicated by Moneycontrol analysis on June 12, 2025. Mankind Pharma is a constituent of the NIFTY MIDCAP 150 index.
Financial Performance
Mankind Pharma's financial performance shows consistent growth in revenue and net profit over the years.
Consolidated Revenue:
The company's annual performance also reflects strong financials.
| Year | Revenue (Cr) | Net Profit (Cr) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 6,214.43 | 1,281.36 | 31.59 | 121.39 | 26.79 | 0.05 |
| 2022 | 7,781.56 | 1,438.51 | 35.78 | 157.68 | 23.28 | 0.14 |
| 2023 | 8,749.43 | 1,297.25 | 32.00 | 190.30 | 17.24 | 0.02 |
| 2024 | 10,334.77 | 1,926.56 | 47.75 | 239.04 | 20.43 | 0.02 |
| 2025 | 12,207.44 | 1,998.88 | 49.28 | 347.37 | 13.89 | 0.59 |
The standalone financial data provides a detailed look at Mankind Pharma's income statement.
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | 9,497 | 9,264 | 8,127 | 7,257 | 5,529 |
| Other Income | 493 | 266 | 162 | 162 | 148 |
| Total Income | 9,991 | 9,531 | 8,289 | 7,419 | 5,677 |
| Total Expenditure | 7,313 | 7,257 | 6,699 | 5,578 | 4,229 |
| EBIT | 2,738 | 2,274 | 1,590 | 1,841 | 1,448 |
| Interest | 371 | 14 | 27 | 43 | 7 |
| Tax | 421 | 436 | 314 | 462 | 355 |
| Net Profit | 1,945 | 1,823 | 1,248 | 1,335 | 1,084 |
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
